Unknown

Dataset Information

Improving the clinical management of traumatic brain injury through the pharmacokinetic modeling of peripheral blood biomarkers.


ABSTRACT:

Background

Blood biomarkers of neurovascular damage are used clinically to diagnose the presence severity or absence of neurological diseases, but data interpretation is confounded by a limited understanding of their dependence on variables other than the disease condition itself. These include half-life in blood, molecular weight, and marker-specific biophysical properties, as well as the effects of glomerular filtration, age, gender, and ethnicity. To study these factors, and to provide a method for markers' analyses, we developed a kinetic model that allows the integrated interpretation of these properties.

Methods

The pharmacokinetic behaviors of S100B (monomer and homodimer), Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase L1 were modeled using releva

SUBMITTER: Dadas A 

PROVIDER: S-EPMC5402680 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature